Integrative Training in Addictions

What’s new with the NIDA training grant at University of Chicago?

John Schneider, MD, MPH has received the 2021 Arete Award for Civic Responsibility!


Our T32 Training Faculty John Schneider, MD, MPH, has received the 2021 Arete Award for Civic Responsibility from the American Community Schools of Athens (ACS Athens). ACH Athens is an international school located in Athens, Greece, and Dr. Schneider received this award for providing generous guidance to the school during their COVID-19 response. Congratulations, Dr. Schneider.

"A Measure of Pleasure"

For nearly two decades psychologist Andrea King has followed a group of social drinkers to find out why only some develop alcohol use disorder.

Dr. Ming Xu and his colleagues have recently published exciting new findings on a potential new treatment for cocaine addiction


Coming Soon:

The Integrative Training in Addictions

Fourth Annual Retreat

The NIDA T32 Training Program at The University of Chicago provides a unique multidisciplinary opportunity for both pre and postdoctoral trainees interested in addiction and substance abuse research.  Our training faculty include world-renowned experts in addiction research at every level, from molecular genetics and cellular approaches, to behavior, epidemiology and treatment.  With this breadth of faculty expertise, we aim to educate trainees in the multiple dimensions of this complex social and biological problem.

The University of Chicago has a long record of commitment to drug abuse research, beginning in 1972 when the NIDA-funded Drug Abuse Research Center was established.  Since then, our faculty have included pioneers of addiction research, including Jerry Jaffe, Lewis Seiden, Daniel X Freedman, Bob Schuster, Marian Fischman and Chris-Ellyn Johanson.   Building on this long tradition, current faculty include leaders in neuropharmacology and behavioral pharmacology of addiction, using both animal models and human subjects, as well as key epidemiological and public policy research. The University has recently expanded its commitment to neuroscience through new investments in genetics as well as systems/computational neuroscience and clinical research. These significant investments create a rich intellectual environment with exciting new opportunities addiction research.